Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.

Molecular interactions between RGD peptides and integrins are known to mediate many biological and pathological processes. This has led to an increased interest in the development of RGD compounds with high affinity and improved selectivity for integrin receptors. In this study, we synthesized and evaluated a series of multimeric RGD compounds constructed on a dicarboxylic acid-containing near-infrared (NIR) fluorescent dye (cypate) for tumor targeting. An array of NIR fluorescent RGD compounds was prepared efficiently, including one RGD monomer (cypate-(RGD)(2)-NH(2)), two RGD dimers (cypate-(RGD)(2)-NH(2) and cypate-(RGD-NH(2))(2)), one trimer (cypate-(RGD)(3)-NH(2)), two tetramers (cypate-(RGD)(4)-NH(2) and cypate-[(RGD)(2)-NH(2)](2)), one hexamer (cypate-[(RGD)(3)-NH(2)](2)), and one octamer (cypate-[(RGD)(4)-NH(2)](2)). The binding affinity of the multimeric RGD compounds for alpha(v)beta(3) integrin receptor (ABIR) showed a remarkable increase relative to the monomer cypate-RGD-NH(2). Generally, the divalent linear arrays of the multimeric RGD units bound the ABIR with slightly higher affinity than their monovalent analogues. These results suggest that the receptor binding affinity was not only dependent on the number of RGD moieties but also on the spatial alignments of the pendant peptides. Internalization of the compounds by ABIR-positive tumor cells (A549) was monitored by NIR fluorescence microscopy. The data showed that endocytosis of the octameric RGD derivative was significantly higher by comparison to other compounds in this study. In vivo noninvasive optical imaging and biodistribution data showed that the compounds were retained in A549 tumor tissue. These results clearly demonstrated that an array of simple RGD tripeptides on a NIR fluorescent dye core can be recognized by ABIR. Optimization of the spatial alignment of the RGD moieties through careful molecular design and library construction could induce multivalent ligand-receptor interactions useful for in vivo tumor imaging and tumor-targeted therapy.

[1]  D. Taverna,et al.  A Direct Test of Potential Roles for β3 and β5 Integrins in Growth and Metastasis of Murine Mammary Carcinomas , 2005 .

[2]  Sanjiv S. Gambhir,et al.  Near-Infrared Fluorescent RGD Peptides for Optical Imaging of Integrin αvβ3 Expression in Living Mice , 2005 .

[3]  Thorsten Persigehl,et al.  Inhibition of Tumor Growth by RGD Peptide–Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature , 2005, Clinical Cancer Research.

[4]  Kyung-Han Lee,et al.  PMA-enhanced neutrophil [18F]FDG uptake is independent of integrin occupancy but requires PI3K activity. , 2005, Nuclear medicine and biology.

[5]  O. McCarty,et al.  GPVI and integrin αIIbβ3 signaling in platelets , 2005, Journal of thrombosis and haemostasis : JTH.

[6]  Hung-Yun Lin,et al.  Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. , 2005, Endocrinology.

[7]  Zhimin Shen,et al.  Synthesis, in vitro, and in vivo characterization of an integrin αvβ3-targeted molecular probe for optical imaging of tumor , 2005 .

[8]  A. Bosserhoff,et al.  Integrin signaling in malignant melanoma , 2005, Cancer and Metastasis Reviews.

[9]  E. W. Meijer,et al.  A supramolecular approach to multivalent target-specific MRI contrast agents for angiogenesis. , 2005, Chemical communications.

[10]  Britton Chance,et al.  Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  F. Mitjans,et al.  αvβ5-Integrins mediate early steps of metastasis formation , 2005 .

[12]  Xiu‐da Shen,et al.  Cyclic RGD Peptides With High Affinity for α5β1 Integrin Protect Genetically Fat Zucker Rat Livers From Cold Ischemia/Reperfusion Injury , 2005 .

[13]  H. Ghandehari,et al.  Targeting tumor angiogenic vasculature using polymer-RGD conjugates. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[14]  D. Sheppard,et al.  Mice Lacking the Integrin β5 Subunit Have Accelerated Osteoclast Maturation and Increased Activity in the Estrogen‐Deficient State , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  F. Mitjans,et al.  Alphavbeta5-integrins mediate early steps of metastasis formation. , 2005, European journal of cancer.

[16]  Zhen Cheng,et al.  Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. , 2005, Bioconjugate chemistry.

[17]  D. Taverna,et al.  Growth and Metastasis of Murine Mammary Carcinomas 5 Integrins in β 3 and β A Direct Test of Potential Roles for Updated , 2005 .

[18]  Sharon Bloch,et al.  Multivalent carbocyanine molecular probes: synthesis and applications. , 2005, Bioconjugate chemistry.

[19]  W. Berdel,et al.  Inhibition of Tumor Growth by RGD Peptide Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature. , 2004 .

[20]  R. Moats,et al.  In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor Xenografts , 2004, Cancer Research.

[21]  Mark P. Lewis,et al.  αv integrins play an important role in myofibroblast differentiation , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[22]  T. Tsuji Physiological and Pathological Roles of α3β1 Integrin , 2004, The Journal of Membrane Biology.

[23]  S. Achilefu Lighting up Tumors with Receptor-Specific Optical Molecular Probes , 2004, Technology in cancer research & treatment.

[24]  Samuel Achilefu,et al.  Targeting the expression of integrin receptors in tumors , 2004, SPIE BiOS.

[25]  Sharon Bloch,et al.  Polyvalent carbocyanine molecular beacons for molecular recognitions. , 2004, Journal of the American Chemical Society.

[26]  J. Reddy,et al.  Folate-targeted chemotherapy. , 2004, Advanced drug delivery reviews.

[27]  M. Green,et al.  Folate-receptor-targeted radionuclide imaging agents. , 2004, Advanced drug delivery reviews.

[28]  Jean-Luc Coll,et al.  Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis. , 2004, Journal of the American Chemical Society.

[29]  D. Beuningen,et al.  Irradiation and Various Cytotoxic Drugs Enhance Tyrosine Phosphorylation and β1-Integrin Clustering in Human A549 Lung Cancer Cells in a Substratum-Dependent Manner in Vitro , 2004, Strahlentherapie und Onkologie.

[30]  B. Hudson,et al.  αvβ3 and αvβ5 Integrins Bind Both the Proximal RGD Site and Non-RGD Motifs within Noncollagenous (NC1) Domain of the α3 Chain of Type IV Collagen , 2004, Journal of Biological Chemistry.

[31]  M. Schwaiger,et al.  [18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. , 2004, Bioconjugate chemistry.

[32]  B. Hudson,et al.  Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the alpha3 chain of type IV collagen: implication for the mechanism of endothelia cell adhesion. , 2004, The Journal of biological chemistry.

[33]  Michael S. Pepper,et al.  αvβ3 and αvβ5 integrin antagonists inhibit angiogenesis in vitro , 2004, Angiogenesis.

[34]  Stephen Albert Johnston,et al.  Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. , 2003, Cancer letters.

[35]  E. Ruoslahti The RGD story: a personal account. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[36]  V. Raman,et al.  Real time non‐invasive imaging of receptor–ligand interactions in vivo , 2003, Journal of cellular biochemistry.

[37]  J. Frangioni In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[38]  R. Roy A Decade of Glycodendrimer Chemistry , 2003 .

[39]  K. Honn,et al.  Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. , 2003, Cancer research.

[40]  Horst Kessler,et al.  Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation. , 2003, Chemistry.

[41]  Yunpeng Ye,et al.  Synthesis and characterization of a macrocyclic near-infrared optical scaffold. , 2003, Journal of the American Chemical Society.

[42]  G. Tucker Alpha v integrin inhibitors and cancer therapy. , 2003, Current opinion in investigational drugs.

[43]  F. Lubin,et al.  Regulation of epithelial cell cytokine responses by the α3β1 integrin , 2003 .

[44]  S. Goodman,et al.  alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro. , 2003, Angiogenesis.

[45]  F. Lubin,et al.  Regulation of epithelial cell cytokine responses by the alpha3beta1 integrin. , 2003, Immunology.

[46]  E. Fleck,et al.  PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4. , 2002, Circulation research.

[47]  Horst Kessler,et al.  The structures of integrins and integrin-ligand complexes: implications for drug design and signal transduction. , 2002, Angewandte Chemie.

[48]  Woo Kyung Moon,et al.  A Receptor‐Targeted Near‐Infrared Fluorescence Probe for In Vivo Tumor Imaging , 2002, Chembiochem : a European journal of chemical biology.

[49]  F. Carreiras,et al.  Involvement of αvβ 3 integrin and disruption of endothelial fibronectin network during the adhesion of the human ovarian adenocarcinoma cell line IGROV1 on the human umbilical vein cell extracellular matrix , 2002, International journal of cancer.

[50]  E. Fleck,et al.  PPAR Inhibits TGF TGF TGF – Induced 5 Integrin Transcription in Vascular Smooth Muscle Cells by Interacting With Smad 4 , 2002 .

[51]  I. Kirby,et al.  Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by αvβ1 integrin and can be modulated by changes in β1 integrin function , 2001, Journal of Gene Medicine.

[52]  S. Achilefu,et al.  Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. , 2001, Journal of biomedical optics.

[53]  J. Sacchettini,et al.  Multivalent protein-carbohydrate interactions. A new paradigm for supermolecular assembly and signal transduction. , 2001, Biochemistry.

[54]  M Schwaiger,et al.  Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[55]  S. Mousa,et al.  Human platelet αIIbβ3 integrin binding affinity and specificity of SJ874: antiplatelet efficacy versus aspirin , 2000 .

[56]  S. Achilefu,et al.  Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. , 2000, Investigative radiology.

[57]  Y. Takada,et al.  Human Parechovirus 1 Utilizes Integrins αvβ3 and αvβ1 as Receptors , 2000, Journal of Virology.

[58]  R. Hynes,et al.  Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. , 2000, The Journal of clinical investigation.

[59]  R. Midura,et al.  Activation of Integrin αVβ3 Regulates Cell Adhesion and Migration to Bone Sialoprotein , 2000 .

[60]  S. Mousa,et al.  Human platelet alphaIIbeta3 integrin binding affinity and specificity of SJ874: antiplatelet efficacy versus aspirin. , 2000, Coronary artery disease.

[61]  R. Midura,et al.  Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. , 2000, Experimental cell research.

[62]  R. Langlois,et al.  Photodynamic Therapy: Tumor Targeting with Adenoviral Proteins , 1999, Photochemistry and photobiology.

[63]  Horst Kessler,et al.  N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists , 1999 .

[64]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[65]  S. Teitelbaum,et al.  The Integrin αvβ5 Is Expressed on Avian Osteoclast Precursors and Regulated by Retinoic Acid , 1999 .

[66]  S. Teitelbaum,et al.  The integrin alphavbeta5 is expressed on avian osteoclast precursors and regulated by retinoic acid. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[67]  S. Goodman,et al.  N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. , 1999, Journal of medicinal chemistry.

[68]  F. Ross,et al.  Differential Expression of αv Integrins in K1735 Melanoma Cells , 1999, Invasion and Metastasis.

[69]  S. Teitelbaum,et al.  Granulocyte macrophage-colony stimulating factor reciprocally regulates alphav-associated integrins on murine osteoclast precursors. , 1998, Molecular endocrinology.

[70]  George M Whitesides,et al.  Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.

[71]  X. Li,et al.  Differential expression of alphav integrins in K1735 melanoma cells. , 1998, Invasion & metastasis.

[72]  E. Maxwell,et al.  Biochemical Characterization of the Binding of Echistatin to Integrin αvβ3 Receptor , 1997 .

[73]  M. Crow,et al.  The inhibition of vascular smooth muscle cell migration by peptide and antibody antagonists of the alphavbeta3 integrin complex is reversed by activated calcium/calmodulin- dependent protein kinase II. , 1997, The Journal of clinical investigation.

[74]  S. T. Pottratz,et al.  Gamma‐interferon inhibits Pneumocystis carinii attachment to lung cells by decreasing expression of lung cell‐surface integrins , 1997, European journal of clinical investigation.

[75]  E. Maxwell,et al.  Biochemical characterization of the binding of echistatin to integrin alphavbeta3 receptor. , 1997, The Journal of pharmacology and experimental therapeutics.

[76]  V. Hruby,et al.  Melanotropic peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[77]  R. Swerlick,et al.  Integrins: Role in Cell Adhesion and Communication , 1996, Annals of the New York Academy of Sciences.

[78]  K. Burridge,et al.  Focal adhesions, contractility, and signaling. , 1996, Annual review of cell and developmental biology.

[79]  P. Reilly,et al.  The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1. , 1995, Journal of immunology.

[80]  L. Campisi,et al.  Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2 , 1994, Journal of virology.

[81]  D. Sheppard,et al.  Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein. , 1992, The Journal of biological chemistry.

[82]  R. Timpl,et al.  Arg‐Gly‐Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1 , 1991, FEBS letters.

[83]  E. Ruoslahti,et al.  Arg-Gly-Asp: A versatile cell recognition signal , 1986, Cell.

[84]  E. Ruoslahti,et al.  The cell attachment determinant in fibronectin , 1985, Journal of cellular biochemistry.

[85]  Erkki Ruoslahti,et al.  Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule , 1984, Nature.